FindTrial
Sign In

Effect of oral zinc supplementation in reducing bilirubin levels in babies requiring phototherapy

Effect of Oral Zinc supplementation on Serum Bilirubin Levels in Late preterm and Term Neonates Undergoing Phototherapy-A Randomized controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095855
Enrollment
73
Registered
2025-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P84- Other problems with newborn

Interventions

Intervention1: Oral Zinc Supplementation For Neonates Requiring Phototherapy: Oral zinc Acetate 5MG/day(0.25ml) Twice daily for 3 days for neonates requiring phototherapy Control Intervention1: Placeb

Sponsors

Venigandla Nagaraju Principal Investigator
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All healthy late preterm and term neonates requiring phototherapy within 7 days of life

Exclusion criteria

Exclusion criteria: Preterm neonates of less than 34 weeks Neonates with direct hyperbilirubinemia Severe sepsis Hemolytic jaundice

Design outcomes

Primary

MeasureTime frame
To determine the effect of zinc on serum bilirubin in late preterm and tern neonates with hyperbilirubinemia undergoing phototherapyTimepoint: 12th hourly, 24th hourly, 48th hourly after starting phototherapy—

Secondary

MeasureTime frame
To determine the duration of phototherapyTimepoint: 7 days—

Countries

India

Contacts

Public ContactDr.E.vijayabharathi

Sri venkateshwaraa medical college hospital and research centre

drviba@gmail.com9442605567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026